Sheikh Abdulla bin Mohamed Al Hamed, Chairman of the Department of Health – Abu Dhabi (DoH), affirmed that children’s health and well-being is a fundamental pillar of all efforts and a priority in the healthcare ecosystem in the Emirate of Abu Dhabi. As the world observes International Childhoo ..
(MENAFN - Emirates News Agency (WAM)) ABU DHABI, 14th February, 2021 (WAM) Abdulla bin Mohamed Al Hamed, Chairman of the Department of Health Abu Dhabi (DoH), today visited Mubadala Health s booth located at The Galleria Al Maryah Island for administering COVID-19 vaccines. The opening of the new Mubadala Health s booth, in collaboration with Abu Dhabi Global Market (ADGM) comes in line with the dedicated efforts to encourage the vaccination intake among members of the community to curb the spread of the COVID-19 virus.
Abdulla Al Hamed was welcomed by Hasan Jasem Al Nowais, the CEO of Mubadala Health, and Dhaher bin Dhaher Al Mheiri, CEO of ADGM s Registration Authority, who took Al Hamed for a tour to have a look at the services being offered at the booth from Sunday to Thursday from 10 am to 7 pm.
Abu Dhabi: The Abu Dhabi government recently called upon residents to volunteer for the Phase III trials of another COVID-19 vaccine. Developed in Russia, this vaccine will be tested on at least 500 people in Abu Dhabi.
The Department of Health Abu Dhabi (DoH), the emirate’s health regulator also released eligibility criteria to sign up for the trials. Here is everything you need to know about the second COVID-19 vaccine trial to be hosted in the UAE so far.
Who developed this vaccine?
This particular COVID-19 vaccine has been developed in Russia. It was created by the Russian Ministry of Health’s Gamaleya National Research Institute of Epidemiology and Microbiology. Gamaleya, a medical research institute is headquartered in Moscow, and is named after Russian scientist, Nikolay Gamaleya, a pioneer in microbiology and vaccine research.